Avoiding a Repeat Sternotomy in Recurrent Carcinoid Heart Disease
- PMID: 34317288
- PMCID: PMC8298780
- DOI: 10.1016/j.jaccas.2020.03.001
Avoiding a Repeat Sternotomy in Recurrent Carcinoid Heart Disease
Keywords: pulmonic valve disease; right heart failure; serotonin; transcatheter valve replacement; tricuspid valve disease; valvulopathy.
Comment on
- doi: 10.1016/j.jaccas.2019.11.089
References
-
- Zacks J, Cánovas E, Lavine R, Warner RRP. Early recurrence of carcinoid valvulopathy after valve replacement. Paper presented at: European Neuroendocrine Tumor Society 11th Annual Conference; May 5–7, 2014; Barcelona, Spain.
-
- Glasberga S, Atlanb J, Korachb A, et al. Surgical management of carcinoid valve disease – mechanical vs. tissue valves. Paper presented at: European Neuroendocrine Tumor Society 12th Annual Conference; March 11–13, 2015; Barcelona, Spain.
-
- U.S. Food and Drug Administration FDA Approves Xermelo for Carcinoid Syndrome Diarrhea. February 28, 2017. https://www.fda.gov/news-events/press-announcements/fda-approves-xermelo... Available at: Accessed December 1, 2019.
-
- Castillo J.G., Milla F., Adams D.H. Surgical management of carcinoid heart valve disease. Semin Thorac Cardiovasc Surg. 2012;24:254–260. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
